BAIT
CARM1
PRMT4
coactivator-associated arginine methyltransferase 1
GO Process (9)
GO Function (12)
GO Component (4)
Gene Ontology Biological Process
- cellular lipid metabolic process [TAS]
- histone H3-R17 methylation [ISS]
- histone H3-R2 methylation [IMP]
- histone methylation [IDA, ISS]
- peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [IBA]
- positive regulation of fat cell differentiation [ISS]
- regulation of intracellular estrogen receptor signaling pathway [ISS]
- regulation of transcription, DNA-templated [IBA, ISS]
- small molecule metabolic process [TAS]
Gene Ontology Molecular Function- beta-catenin binding [TAS]
- histone methyltransferase activity [IDA]
- histone methyltransferase activity (H3-R17 specific) [ISS]
- histone-arginine N-methyltransferase activity [IBA]
- ligand-dependent nuclear receptor transcription coactivator activity [ISS]
- lysine-acetylated histone binding [ISS]
- protein binding [IPI]
- protein methyltransferase activity [ISS]
- protein-arginine N-methyltransferase activity [ISS]
- protein-arginine omega-N asymmetric methyltransferase activity [IBA, ISS]
- transcription coactivator activity [ISS]
- transcription regulatory region DNA binding [ISS]
- beta-catenin binding [TAS]
- histone methyltransferase activity [IDA]
- histone methyltransferase activity (H3-R17 specific) [ISS]
- histone-arginine N-methyltransferase activity [IBA]
- ligand-dependent nuclear receptor transcription coactivator activity [ISS]
- lysine-acetylated histone binding [ISS]
- protein binding [IPI]
- protein methyltransferase activity [ISS]
- protein-arginine N-methyltransferase activity [ISS]
- protein-arginine omega-N asymmetric methyltransferase activity [IBA, ISS]
- transcription coactivator activity [ISS]
- transcription regulatory region DNA binding [ISS]
Homo sapiens
PREY
SEC23B
CDA-II, CDAII, CDAN2, HEMPAS, RP11-379J5.1
Sec23 homolog B (S. cerevisiae)
GO Process (1)
GO Function (0)
GO Component (3)
Gene Ontology Biological Process
Gene Ontology Cellular Component
Homo sapiens
Negative Genetic
Mutations/deletions in separate genes, each of which alone causes a minimal phenotype, but when combined in the same cell results in a more severe fitness defect or lethality under a given condition. This term is reserved for high or low throughput studies with scores.
Publication
Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.
Identification of effective combination therapies is critical to address the emergence of drug-resistant cancers, but direct screening of all possible drug combinations is infeasible. Here we introduce a CRISPR-based double knockout (CDKO) system that improves the efficiency of combinatorial genetic screening using an effective strategy for cloning and sequencing paired single guide RNA (sgRNA) libraries and a robust statistical scoring ... [more]
Nat. Biotechnol. Mar. 20, 2017; 0(); [Pubmed: 28319085]
Quantitative Score
- -3.919 [Confidence Score]
Throughput
- High Throughput
Ontology Terms
- phenotype: growth abnormality (HP:0001507)
Additional Notes
- CRISPR GI screen
- Cell Line:K562 (EFO:0002067)
- Experimental Setup:Toxin Exposure: Ricin at LD50 (first two pulses: 0.25 ng/ml ricin, third pulse: 0.3 ng/ml, fourth pulse: 0.35 ng/ml)
- GIST: A-phenotypic negative genetic interaction
- Library:Ricin-CDKO CRISPRn library
- Significance Threshold: q-value<0.05
Curated By
- BioGRID